Basel, March 20, 2014-Novartis has announced the launch of the Lucentis ® (ranibizumab) pre-filled syringe (PFS) in Germany, with other markets to follow throughout 2014. The Lucentis PFS ...

Diabetic retinopathy is the leading cause of blindness among working age adults and affects nearly 7.7 million people in the U.S. 1,2 The Lucentis 0.3 mg PFS is now the first syringe prefilled ...

The PFS eliminates several steps in the preparation process for the physician. With the Lucentis PFS, physicians attach the injection needle to the syringe and adjust the dose prior to administration.

Like the Lucentis 0.5 mg vial, the 0.5 mg prefilled syringe (PFS) is approved for patients with wet age-related macular degeneration (AMD) and macular edema after retinal vein occlusion (RVO).

Lucentis is already available as 6mg/mL and 10mg/mL strength solutions for ophthalmic intravitreal injection in single-use vials and as prefilled syringes for the 10mg/mL strength. The 0.5mg PFS ...

Roche Holding AG RHHBY announced that the FDA has approved the Lucentis 0.3 mg prefilled syringe (“PFS”) as a new method of administering medicine for all forms of diabetic retinopathy.

The PFS has been approved for use in the treatment ... Roche’s ophthalmology portfolio also comprises Susvimo and Lucentis. Susvimo (previously called Port Delivery System with ranibizumab ...

Outlook Therapeutics’ eye disease drug has failed to match Roche’s Lucentis in a key trial. The biotech brushed off the failure, noting positive details and vowing to seek FDA approval ...

Novartis announces the launch in Europe of the Lucentis pre-filled syringe (PFS), which is specifically designed for intraocular injection The Lucentis PFS can lead to improved patient treatment ...

Basel, March 20, 2014-Novartis has announced the launch of the Lucentis ® (ranibizumab) pre-filled syringe (PFS) in Germany, with other markets to follow throughout 2014. The Lucentis PFS, which ...

Novartis announces the launch in Europe of the Lucentis pre-filled syringe (PFS), which is specifically designed for intraocular injection - The Lucentis PFS can lead to improved patient treatment ...

Novartis International AG / Novartis introduces Lucentis® in state of the art pre-filled syringe . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible ...